Acute Agitation in the ED — De-escalation and Medications

Key Points

• Treat agitation as a symptom and actively search for medical and toxicologic causes.
• Verbal de-escalation and voluntary oral treatment are preferred when safely possible.
• The medication goal is calm participation in care, not unconsciousness.
• Use benzodiazepines preferentially for stimulant intoxication and alcohol or benzodiazepine withdrawal.
• Antipsychotics are useful for psychosis and many undifferentiated agitation presentations.
• Severely violent agitation may require rapid parenteral medication and, in selected cases, ketamine with full monitoring capability.
• Physical restraints require frequent reassessment, attention to positioning, and rapid removal once the immediate danger passes.
• Persistent agitation after sedation should prompt renewed evaluation for hypoxia, hyperthermia, hypoglycemia, head injury, toxidromes, or delirium.

Algorithm

1. Secure the environment, summon adequate trained staff, and remove dangerous objects.
2. Use a calm single spokesperson, respect personal space, offer choices, and attempt verbal de-escalation.
3. Check oxygen saturation, respiratory effort, pulse, blood pressure, temperature, and point-of-care glucose as early as safety permits.
4. If dangerous agitation persists, select medication based on the likely cause and route that can be administered safely.
5. Apply physical restraints only when necessary for immediate safety and position the patient to protect breathing and circulation.
6. Once controlled, reassess airway, ventilation, temperature, trauma, neurologic status, and medication effects.
7. Perform targeted testing and treat the underlying intoxication, withdrawal, delirium, psychiatric illness, or medical disease.
8. Document indication, alternatives attempted, response, monitoring, and the plan to discontinue restraints.

Clinical Synopsis & Reasoning

Agitation is a syndrome, not a diagnosis. Potential causes include delirium, stimulant intoxication, alcohol or sedative withdrawal, hypoxia, hypoglycemia, head injury, intracranial disease, infection, serotonin toxicity, anticholinergic toxicity, endocrine emergencies, medication effects, psychosis, mania, trauma, pain, and environmental stress. Abrupt onset, fluctuating attention, disorientation, abnormal vital signs, new neurologic findings, or older age should increase concern for a medical delirium rather than a primary psychiatric condition.

The first assessment is environmental: remove unnecessary personnel and stimuli, identify exits, keep the clinician at a safe distance, and use a calm single spokesperson. Offer food, water, a quieter space, or voluntary oral medication when appropriate. Respectful verbal de-escalation can reduce the need for restraints and injections. Physical restraints are reserved for immediate safety threats and should be accompanied by medication and monitoring when prolonged struggle would increase physiologic risk.

If medication is needed, choose it based on the likely cause. Antipsychotics are useful for many psychotic or undifferentiated agitation states. Benzodiazepines are preferred for stimulant intoxication and alcohol or benzodiazepine withdrawal. Ketamine can produce rapid control in extreme violent agitation when immediate safety requires it, but airway and hemodynamic monitoring are essential. Avoid simply stacking sedatives without reassessing respiratory status and the evolving diagnosis.

Treatment Strategy & Disposition

Attempt verbal de-escalation and oral medication first when it is safe and feasible. Oral olanzapine, risperidone, or other local-protocol agents can be effective in cooperative patients. For severe agitation requiring parenteral medication, options include IM or IV benzodiazepines, antipsychotics such as droperidol or olanzapine, or combinations chosen according to the clinical situation. Droperidol and haloperidol require awareness of QT prolongation and extrapyramidal effects, although serious arrhythmia is uncommon at commonly used ED doses in appropriately selected patients.

In alcohol or benzodiazepine withdrawal, benzodiazepines treat the underlying pathophysiology. In stimulant intoxication, benzodiazepines are also generally first-line, with antipsychotics added when psychosis or severe agitation persists. Avoid benzodiazepine monotherapy when respiratory depressant intoxication is likely unless there is another compelling indication. If ketamine is used for immediate control of severe violent agitation, prepare for hypersalivation, emergence reactions, hypertension, vomiting, and possible airway intervention.

After initial control, remove restraints as soon as it is safe and complete the medical evaluation. Check glucose early, obtain temperature and oxygen saturation, and perform focused neurologic and trauma examinations. Order laboratory or imaging studies according to history and examination rather than a universal psychiatric clearance panel. Patients with delirium, persistent abnormal vital signs, significant intoxication or withdrawal, hyperthermia, rhabdomyolysis, trauma, or other medical instability require medical admission or continued treatment rather than psychiatric disposition.

Epidemiology / Risk Factors

• Agitation is common in emergency care and may accompany psychiatric illness, intoxication, withdrawal, delirium, dementia, neurologic disease, or severe medical illness.
• Substance-related agitation varies with local drug supply and can involve methamphetamine, cocaine, synthetic stimulants, PCP-like agents, or mixed intoxication.
• Older adults with agitation have a high prevalence of delirium and medical causes.
• Patients with developmental disabilities or autism may become agitated from pain, sensory overload, or communication barriers and benefit from individualized environmental strategies.
• Prior coercive medical experiences can worsen agitation, making trauma-informed communication clinically important.

Investigations

Common ED Options (Examples)

Pharmacology

Prognosis / Complications

• Prognosis depends on the underlying cause rather than the agitation itself.
• Prompt treatment of hypoxia, hypoglycemia, hyperthermia, withdrawal, or toxicologic causes can rapidly reverse dangerous physiology.
• Prolonged struggle, hyperthermia, severe acidosis, and rhabdomyolysis are associated with higher risk of collapse and organ injury.
• Medication adverse events are uncommon with careful dosing and monitoring but include respiratory depression, hypotension, dystonia, and dysrhythmia.
• Patients with primary psychiatric illness generally recover well from the acute behavioral episode when safety, medication continuity, and follow-up needs are addressed.

Patient Education / Counseling

• After the crisis resolves, explain what medications and restraints were used and why, especially if the patient has incomplete memory of the event.
• Review substance use, withdrawal risk, prescribed psychiatric medication adherence, and access to outpatient mental-health care.
• For recurrent agitation, develop an individualized crisis plan that includes effective verbal approaches and medications that previously helped or caused adverse effects.
• Discuss driving, machinery, and fall precautions after sedating medication until effects have fully resolved.
• Patients and families should receive clear warning signs for returning, including confusion, fever, seizure, new neurologic symptoms, suicidal or homicidal intent, or recurrent uncontrollable behavior.
• Use nonstigmatizing language and distinguish behavior from diagnosis in discharge documentation and counseling.

Notes

Safe agitation care is iterative. Every sedative dose should be followed by renewed diagnostic assessment because the ability to examine the patient often improves after the immediate danger has been controlled.

A universal laboratory panel is not a substitute for history and examination. Testing should be directed by age, vital signs, cognition, trauma risk, toxidrome, medication exposure, and the expected psychiatric presentation.

References

1. American College of Emergency Physicians Clinical Policy Resources — Link
2. Project BETA De-escalation and Agitation Resources — Link